Novavax's COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial, also provided immunity against new variants
The Novavax vaccine candidate also appears to be effective against the UK and South African coronavirus variants.
Novavax's COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial, also provided immunity against new variants
USATODAY.com
0 shares
6 views
- More about:
COVID-19- Novavax
- South Africa
You might like
Related news coverage
Johnson & Johnson And Novavax Vaccines May Not Sustain Herd Immunity Against Coronavirus Variants, New Trial Results Reveal
Gothamist
Johnson & Johnson's vaccine is being developed under the leadership of the subsidiary Janssen Vaccines in Leiden, The..
Advertisement
More coverage
Experts Say Those Already Vaccinated Should Still Wear Mask
Watch Video"I wear a mask to keep my patients safe," says emergency medicine physician Jeff Pothof, who received both doses of the..
Newsy
As Coronavirus Rises Past Three Million, Africa Hopes For Vaccine – Analysis
With its large population and fragile health systems, Africa has recorded more than three million Covid-19 cases, still less deadly..
Eurasia Review